blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4371573

EP4371573 - MEDICINAL COMPOSITION FOR TREATING INFLAMMATORY BOWEL DISEASE [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  19.04.2024
Database last updated on 13.11.2024
FormerThe international publication has been made
Status updated on  20.01.2023
Most recent event   Tooltip19.09.2024Change: Validation statespublished on 23.10.2024  [2024/43]
19.09.2024Change - extension statespublished on 23.10.2024  [2024/43]
Applicant(s)For all designated states
National University Corporation Tokai National Higher Education and Research System
1, Furo-cho
Chikusa-ku
Nagoya-shi, Aichi 464-8601 / JP
For all designated states
Mabprotein Co., Ltd.
89-1, Enya-cho
Izumo-shi, Shimane, 693-8501 / JP
[2024/21]
Inventor(s)01 / MAEDA, Keiko
Nagoya-shi, Aichi 464-8601 / JP
02 / FUJISHIRO, Mitsuhiro
Nagoya-shi, Aichi 464-8601 / JP
03 / IKEGAMI, Shuji
Nagoya-shi, Aichi 464-8601 / JP
04 / URANO, Takeshi
Izumo-shi, Shimane 693-8501 / JP
 [2024/21]
Representative(s)Schön, Christoph
Dr. Schön, Neymeyr & Partner mbB
Bavariaring 26
80336 München / DE
[2024/21]
Application number, filing date22842038.607.07.2022
[2024/21]
WO2022JP27035
Priority number, dateJP2021011545813.07.2021         Original published format: JP 2021115458
[2024/21]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2023286694
Date:19.01.2023
Language:JA
[2023/03]
Type: A1 Application with search report 
No.:EP4371573
Date:22.05.2024
Language:EN
[2024/21]
Search report(s)International search report - published on:JP19.01.2023
ClassificationIPC:A61K39/395, A61K45/00, A61P1/04, A61P43/00, C07K16/24, C07K19/00, C12N15/13, C12P21/08
[2024/21]
CPC:
A61P1/04 (EP); A61P43/00 (EP); C07K16/241 (EP);
C07K16/244 (EP); A61K2039/505 (EP); A61K2039/507 (EP);
C07K2317/30 (EP); C07K2317/34 (EP); C07K2317/76 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/21]
TitleGerman:MEDIZINISCHE ZUSAMMENSETZUNG ZUR BEHANDLUNG VON ENTZÜNDLICHER DARMERKRANKUNG[2024/21]
English:MEDICINAL COMPOSITION FOR TREATING INFLAMMATORY BOWEL DISEASE[2024/21]
French:COMPOSITION MÉDICINALE POUR LE TRAITEMENT D'UNE MALADIE INFLAMMATOIRE DE L'INTESTIN[2024/21]
Entry into regional phase06.02.2024Translation filed 
06.02.2024National basic fee paid 
06.02.2024Search fee paid 
06.02.2024Designation fee(s) paid 
06.02.2024Examination fee paid 
Examination procedure06.02.2024Examination requested  [2024/21]
Fees paidRenewal fee
06.02.2024Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]WO0232374  (IMMUNEX CORP [US], et al);
 [Y]WO2020116423  (MABPROTEIN CO LTD [JP])
by applicantWO0056771
 WO0158956
 WO0162285
 WO2004092219
 WO2005047307
 WO2007137984
 WO2010048183
 WO2012085015
 WO2014037899
 WO2014186728
 WO2015032932
 WO2020116423
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.